PSK 3841

Drug Profile

PSK 3841

Alternative Names: HMR 3841; RU 58841

Latest Information Update: 04 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ProStrakan
  • Class Antiacnes; Antiandrogens; Imidazolidines; Nitriles; Small molecules
  • Mechanism of Action Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Acne; Alopecia

Most Recent Events

  • 31 May 2007 No development reported - Phase-I for Acne in USA (Topical)
  • 31 May 2007 No development reported - Phase-I for Alopecia in USA (Topical)
  • 22 Sep 2004 ProSkelia has merged with Strakan to form ProStrakan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top